SlideShare a Scribd company logo
1 of 7
Schedule c 
BIOLOGICAL PRODUCTS AND special PRODUCTS 
Y. NARENDRA 
M.PHARMACY, 
(PHARMACEUTICS)
1.Sera 
2.Solution of serum proteins intended for injection. 
3.Vaccins for parental injections 
. 
4.Toxins. 
5.Antigen. 
6.Antitoxins. 
7.neo_arsphenamine and analogous substances used for the 
specific treatment of infective diseases. 
8.Insulin
9.pitutiary(posterior lobe)extract. 
10.Adrenalin and solutions of salts of adrenaline, 
11.Antibiotics and preparations thereof in form to be administered 
parenterally. 
12.Any other preparation which is meant for parentral administration 
as such or after being made up with solvent or medium or any other 
sterile product and which 
(a)Requires to be in a refrigirator:or 
(b)Does not require to be in a refrigerator. 
13.Steriized surgical ligature and sterilized surgical suture. 
14.bacteriophages. 
15.Opthalmic preparations . 
16.Sterile disposable for single use only.
SPECIAL PROVISIONS RELATING TO BIOLOGICAL AND 
OTHER SPECIAL PRODUCTS 
NAME OF SUBSTANCE; 
if any substance specified in schedule C is advertised or sold as a sold as a 
proprietary medicine or is contained in a medicine so advertised or sold, the proper 
name of the substance shell appear on the label in the manner prescribed in this part. 
CONTAINER; 
no substance specified in schedule C shall be sold or offered for sale unless 
it has been sealed in a previously sterilized container made of glass or any other 
suitable material approved for the purpose by the licensing authority appointed under 
rule 21 ,
LABELLING OF MEDICAL DEVICES: 
The labelling of medical devices shall conform to the Indian standards 
specifications laid down from time to time by the bureau of Indian standards in addition to 
any other requirement prescribed under the sais rules . 
PROHIBITION OF SALE OF SUBSTANCE AFTER PRESCRIBED DATE: 
No person shall sell, or exhibit for sale any substances specified in schedule C 
after the date recorded on the container, label or wrapper as the date up to which the 
substance may be expected to retain a potency not less then, not to acquire a toxicity 
greater then that required or permitted by the prescribed test as the case may be 
STANDARDS: 
every substance specified in schedules C and C(1) intended for sale shall 
conform with the standards of strength, quality, and purity specified in these in these rules 
and in schedule applied to samples taken from the final product after every 
manufacturing process has been completed.
TEST FOR STERNGTH ANA QUALITY: 
TEST FOR STERILITY ; 
TEST FOR PRESCENCE OF LIVING AEROBIC OR ANAEROBIC BACTERIA; 
APPLICATION TEST FOR STERILITY; 
a)To samples taken from each of the substance before the operation filling and sealing the 
containers in which it to be issued has commenced except preparations, which after being 
sealed in the containers are to be sterilized by heat ,in a manner satisfactory to the licensing 
authority 
b)To the contents of sample containers when ready for use. 
METHOD OF TESTING; 
1)If at this examination no growth of micro-organisms is found in any tube ,the sample 
may be treated as having passed the test . 
2)If at this examination a growth of micro-organisms is visible ,further samples may be 
taken and the tests may be repeated on the further samples taken.
 TEST FOR FREEDOM FROM ABNORMAL TOXICITY; 
 As per current edition of Indian pharmacopeia in the case 
of each batch of the serum tested by the license or by an 
institution approved by the licensing authority for the 
purpose of carrying out the test on its behalf. 
 TEST FOR PYROGENS; 
 Solution of substances intended for parentral 
administration in large volumes shall be pyrogen free and 
tested for pyrogens .if water or any other aqueous solvent is 
supplied along with the substances for preparing such 
solutions ,it shall also be pyrogens free and tested for 
pyrogens

More Related Content

What's hot

Drug Price Control Order -2013
Drug Price Control Order -2013Drug Price Control Order -2013
Drug Price Control Order -2013Ganesh Shevalkar
 
Goverment analyst and Drug inspector
Goverment analyst and Drug inspectorGoverment analyst and Drug inspector
Goverment analyst and Drug inspectorDr. Supriya Suman
 
Pharmaceutical legislation
Pharmaceutical legislationPharmaceutical legislation
Pharmaceutical legislationChandrika Mourya
 
Drugs & Cosmetics Act 1940 part III
Drugs & Cosmetics Act 1940 part IIIDrugs & Cosmetics Act 1940 part III
Drugs & Cosmetics Act 1940 part IIIPranay Sethiya
 
Schedule M-Jurisprudence
Schedule M-JurisprudenceSchedule M-Jurisprudence
Schedule M-JurisprudenceSaiyam Agarwal
 
Pharmaceutical legislation in India
Pharmaceutical legislation in IndiaPharmaceutical legislation in India
Pharmaceutical legislation in IndiaGanesh Shevalkar
 
Drugs and Cosmetics act, 1940
Drugs and Cosmetics act, 1940Drugs and Cosmetics act, 1940
Drugs and Cosmetics act, 1940Payal Mundada
 
Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985Prakash Mali
 
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954 Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954 Sagar Savale
 
Drug price control order 2013
Drug price control order 2013Drug price control order 2013
Drug price control order 2013Tushar Morankar
 
Drug and price control order
Drug and price control orderDrug and price control order
Drug and price control orderSajalChowdhury4
 
4 medicinal and toilet preparation act 1955
4 medicinal and toilet preparation act 19554 medicinal and toilet preparation act 1955
4 medicinal and toilet preparation act 1955Charudatta Jog
 
Medicinal & toilet preparation act as per pci
Medicinal & toilet preparation act as per pciMedicinal & toilet preparation act as per pci
Medicinal & toilet preparation act as per pciShital Kasale
 
Drug technical advisory board (dtab)
Drug technical advisory board (dtab)Drug technical advisory board (dtab)
Drug technical advisory board (dtab)MukulArora44
 
Medicinal and toilet preparations act and rules,1955 (excise duties)
Medicinal and toilet preparations act and rules,1955 (excise duties)Medicinal and toilet preparations act and rules,1955 (excise duties)
Medicinal and toilet preparations act and rules,1955 (excise duties)Niveditha Shankar
 

What's hot (20)

Drug Price Control Order -2013
Drug Price Control Order -2013Drug Price Control Order -2013
Drug Price Control Order -2013
 
Goverment analyst and Drug inspector
Goverment analyst and Drug inspectorGoverment analyst and Drug inspector
Goverment analyst and Drug inspector
 
Pharmaceutical legislation
Pharmaceutical legislationPharmaceutical legislation
Pharmaceutical legislation
 
Drugs & Cosmetics Act 1940 part III
Drugs & Cosmetics Act 1940 part IIIDrugs & Cosmetics Act 1940 part III
Drugs & Cosmetics Act 1940 part III
 
Schedule M-Jurisprudence
Schedule M-JurisprudenceSchedule M-Jurisprudence
Schedule M-Jurisprudence
 
Pharmaceutical legislation in India
Pharmaceutical legislation in IndiaPharmaceutical legislation in India
Pharmaceutical legislation in India
 
State pharmacy council and joint state pharmacy council
State pharmacy council and joint state pharmacy councilState pharmacy council and joint state pharmacy council
State pharmacy council and joint state pharmacy council
 
Drugs and Cosmetics act, 1940
Drugs and Cosmetics act, 1940Drugs and Cosmetics act, 1940
Drugs and Cosmetics act, 1940
 
Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985
 
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954 Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
Drugs and Magic Remedies (Objectionable Advertisements), 1954 Act,1954
 
Drug price control order 2013
Drug price control order 2013Drug price control order 2013
Drug price control order 2013
 
The Pharmacy act, 1948
The Pharmacy act, 1948The Pharmacy act, 1948
The Pharmacy act, 1948
 
Pharmaceutical legislations
Pharmaceutical legislationsPharmaceutical legislations
Pharmaceutical legislations
 
Drug and price control order
Drug and price control orderDrug and price control order
Drug and price control order
 
4 medicinal and toilet preparation act 1955
4 medicinal and toilet preparation act 19554 medicinal and toilet preparation act 1955
4 medicinal and toilet preparation act 1955
 
Medicinal & toilet preparation act as per pci
Medicinal & toilet preparation act as per pciMedicinal & toilet preparation act as per pci
Medicinal & toilet preparation act as per pci
 
Drug technical advisory board (dtab)
Drug technical advisory board (dtab)Drug technical advisory board (dtab)
Drug technical advisory board (dtab)
 
Medicinal and toilet preparations act and rules,1955 (excise duties)
Medicinal and toilet preparations act and rules,1955 (excise duties)Medicinal and toilet preparations act and rules,1955 (excise duties)
Medicinal and toilet preparations act and rules,1955 (excise duties)
 
Narcotic and psychotropic substances act
Narcotic and psychotropic substances actNarcotic and psychotropic substances act
Narcotic and psychotropic substances act
 
Schedule m
Schedule  m Schedule  m
Schedule m
 

Similar to Schedule c

Module_6_GCLP__LABORATORY_REAGENTS_KITS_MATERIALS.ppt
Module_6_GCLP__LABORATORY_REAGENTS_KITS_MATERIALS.pptModule_6_GCLP__LABORATORY_REAGENTS_KITS_MATERIALS.ppt
Module_6_GCLP__LABORATORY_REAGENTS_KITS_MATERIALS.pptKemalAbdela2
 
EVALUATION OF EFFICACY OF ANTIMICOBIAL PRESERVATIVE
EVALUATION OF EFFICACY OF ANTIMICOBIAL PRESERVATIVEEVALUATION OF EFFICACY OF ANTIMICOBIAL PRESERVATIVE
EVALUATION OF EFFICACY OF ANTIMICOBIAL PRESERVATIVEISF COLLEGE OF PHARMACY MOGA
 
Presentaion on quality control
Presentaion on quality control Presentaion on quality control
Presentaion on quality control Zakir H. Habib
 
GMP Sub Part H, I & J
GMP Sub Part H, I & JGMP Sub Part H, I & J
GMP Sub Part H, I & JHARDIK PATEL
 
3.generic drug product (1) (2)
3.generic drug product (1) (2)3.generic drug product (1) (2)
3.generic drug product (1) (2)FarsanaFiroz1
 
current Good Manufacturing Practices (cGMP)
current Good Manufacturing Practices (cGMP)current Good Manufacturing Practices (cGMP)
current Good Manufacturing Practices (cGMP)Dr. Samia
 
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...MedicReS
 
Extractables and Leachables for Medical Devices
Extractables and Leachables for Medical DevicesExtractables and Leachables for Medical Devices
Extractables and Leachables for Medical DevicesPine Lake Laboratories
 
Quality control laboratory.
Quality control laboratory.Quality control laboratory.
Quality control laboratory.heli1992
 
Radiopharmaceuticals from a regulatory perspective
Radiopharmaceuticals from a regulatory perspectiveRadiopharmaceuticals from a regulatory perspective
Radiopharmaceuticals from a regulatory perspectiveAbhi Keralli
 
Reagent Manufacture Procedure.pdf
Reagent Manufacture Procedure.pdfReagent Manufacture Procedure.pdf
Reagent Manufacture Procedure.pdfSalamSawadogo1
 
Regulation of biosimilar in India
Regulation of biosimilar in India Regulation of biosimilar in India
Regulation of biosimilar in India Palesh Rajkondawar
 
Control of component, containers and closures
Control of component, containers and closuresControl of component, containers and closures
Control of component, containers and closuresJamia Hamdard
 
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptxPART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptxDilsarGohil1
 

Similar to Schedule c (20)

Module_6_GCLP__LABORATORY_REAGENTS_KITS_MATERIALS.ppt
Module_6_GCLP__LABORATORY_REAGENTS_KITS_MATERIALS.pptModule_6_GCLP__LABORATORY_REAGENTS_KITS_MATERIALS.ppt
Module_6_GCLP__LABORATORY_REAGENTS_KITS_MATERIALS.ppt
 
Veterinary vaccine testing and approval
Veterinary vaccine testing and approvalVeterinary vaccine testing and approval
Veterinary vaccine testing and approval
 
EVALUATION OF EFFICACY OF ANTIMICOBIAL PRESERVATIVE
EVALUATION OF EFFICACY OF ANTIMICOBIAL PRESERVATIVEEVALUATION OF EFFICACY OF ANTIMICOBIAL PRESERVATIVE
EVALUATION OF EFFICACY OF ANTIMICOBIAL PRESERVATIVE
 
Presentaion on quality control
Presentaion on quality control Presentaion on quality control
Presentaion on quality control
 
GMP Sub Part H, I & J
GMP Sub Part H, I & JGMP Sub Part H, I & J
GMP Sub Part H, I & J
 
Ao 67
Ao 67Ao 67
Ao 67
 
3.generic drug product (1) (2)
3.generic drug product (1) (2)3.generic drug product (1) (2)
3.generic drug product (1) (2)
 
current Good Manufacturing Practices (cGMP)
current Good Manufacturing Practices (cGMP)current Good Manufacturing Practices (cGMP)
current Good Manufacturing Practices (cGMP)
 
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
FDA 2013 Clinical Investigator Training Course: How to put together an Applic...
 
Extractables and Leachables for Medical Devices
Extractables and Leachables for Medical DevicesExtractables and Leachables for Medical Devices
Extractables and Leachables for Medical Devices
 
Quality control laboratory.
Quality control laboratory.Quality control laboratory.
Quality control laboratory.
 
Sterility tests
Sterility testsSterility tests
Sterility tests
 
Radiopharmaceuticals from a regulatory perspective
Radiopharmaceuticals from a regulatory perspectiveRadiopharmaceuticals from a regulatory perspective
Radiopharmaceuticals from a regulatory perspective
 
Reagent Manufacture Procedure.pdf
Reagent Manufacture Procedure.pdfReagent Manufacture Procedure.pdf
Reagent Manufacture Procedure.pdf
 
Regulation of biosimilar in India
Regulation of biosimilar in India Regulation of biosimilar in India
Regulation of biosimilar in India
 
Control of component, containers and closures
Control of component, containers and closuresControl of component, containers and closures
Control of component, containers and closures
 
Schedule y
Schedule ySchedule y
Schedule y
 
Circular 11/2018/TT-BYT: ON DRUG/DRUG INGREDIENT QUALITY
Circular 11/2018/TT-BYT: ON DRUG/DRUG INGREDIENT QUALITYCircular 11/2018/TT-BYT: ON DRUG/DRUG INGREDIENT QUALITY
Circular 11/2018/TT-BYT: ON DRUG/DRUG INGREDIENT QUALITY
 
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptxPART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
 
Schedule y
Schedule  ySchedule  y
Schedule y
 

More from Malla Reddy College of Pharmacy (20)

Rna secondary structure prediction
Rna secondary structure predictionRna secondary structure prediction
Rna secondary structure prediction
 
Proteomics
ProteomicsProteomics
Proteomics
 
Proteins basics
Proteins basicsProteins basics
Proteins basics
 
Protein structure classification
Protein structure classificationProtein structure classification
Protein structure classification
 
Protein identication characterization
Protein identication characterizationProtein identication characterization
Protein identication characterization
 
Protein modeling
Protein modelingProtein modeling
Protein modeling
 
Primerdesign
PrimerdesignPrimerdesign
Primerdesign
 
Phylogenetic studies
Phylogenetic studiesPhylogenetic studies
Phylogenetic studies
 
Multiple sequence alignment
Multiple sequence alignmentMultiple sequence alignment
Multiple sequence alignment
 
Homology modeling tools
Homology modeling toolsHomology modeling tools
Homology modeling tools
 
Homology modeling
Homology modelingHomology modeling
Homology modeling
 
Genome assembly
Genome assemblyGenome assembly
Genome assembly
 
Genome analysis2
Genome analysis2Genome analysis2
Genome analysis2
 
Genome analysis
Genome analysisGenome analysis
Genome analysis
 
Fasta
FastaFasta
Fasta
 
Drug design intro
Drug design introDrug design intro
Drug design intro
 
Drug design
Drug designDrug design
Drug design
 
Data retrieval
Data retrievalData retrieval
Data retrieval
 
Blast
BlastBlast
Blast
 
Biological databases
Biological databasesBiological databases
Biological databases
 

Schedule c

  • 1. Schedule c BIOLOGICAL PRODUCTS AND special PRODUCTS Y. NARENDRA M.PHARMACY, (PHARMACEUTICS)
  • 2. 1.Sera 2.Solution of serum proteins intended for injection. 3.Vaccins for parental injections . 4.Toxins. 5.Antigen. 6.Antitoxins. 7.neo_arsphenamine and analogous substances used for the specific treatment of infective diseases. 8.Insulin
  • 3. 9.pitutiary(posterior lobe)extract. 10.Adrenalin and solutions of salts of adrenaline, 11.Antibiotics and preparations thereof in form to be administered parenterally. 12.Any other preparation which is meant for parentral administration as such or after being made up with solvent or medium or any other sterile product and which (a)Requires to be in a refrigirator:or (b)Does not require to be in a refrigerator. 13.Steriized surgical ligature and sterilized surgical suture. 14.bacteriophages. 15.Opthalmic preparations . 16.Sterile disposable for single use only.
  • 4. SPECIAL PROVISIONS RELATING TO BIOLOGICAL AND OTHER SPECIAL PRODUCTS NAME OF SUBSTANCE; if any substance specified in schedule C is advertised or sold as a sold as a proprietary medicine or is contained in a medicine so advertised or sold, the proper name of the substance shell appear on the label in the manner prescribed in this part. CONTAINER; no substance specified in schedule C shall be sold or offered for sale unless it has been sealed in a previously sterilized container made of glass or any other suitable material approved for the purpose by the licensing authority appointed under rule 21 ,
  • 5. LABELLING OF MEDICAL DEVICES: The labelling of medical devices shall conform to the Indian standards specifications laid down from time to time by the bureau of Indian standards in addition to any other requirement prescribed under the sais rules . PROHIBITION OF SALE OF SUBSTANCE AFTER PRESCRIBED DATE: No person shall sell, or exhibit for sale any substances specified in schedule C after the date recorded on the container, label or wrapper as the date up to which the substance may be expected to retain a potency not less then, not to acquire a toxicity greater then that required or permitted by the prescribed test as the case may be STANDARDS: every substance specified in schedules C and C(1) intended for sale shall conform with the standards of strength, quality, and purity specified in these in these rules and in schedule applied to samples taken from the final product after every manufacturing process has been completed.
  • 6. TEST FOR STERNGTH ANA QUALITY: TEST FOR STERILITY ; TEST FOR PRESCENCE OF LIVING AEROBIC OR ANAEROBIC BACTERIA; APPLICATION TEST FOR STERILITY; a)To samples taken from each of the substance before the operation filling and sealing the containers in which it to be issued has commenced except preparations, which after being sealed in the containers are to be sterilized by heat ,in a manner satisfactory to the licensing authority b)To the contents of sample containers when ready for use. METHOD OF TESTING; 1)If at this examination no growth of micro-organisms is found in any tube ,the sample may be treated as having passed the test . 2)If at this examination a growth of micro-organisms is visible ,further samples may be taken and the tests may be repeated on the further samples taken.
  • 7.  TEST FOR FREEDOM FROM ABNORMAL TOXICITY;  As per current edition of Indian pharmacopeia in the case of each batch of the serum tested by the license or by an institution approved by the licensing authority for the purpose of carrying out the test on its behalf.  TEST FOR PYROGENS;  Solution of substances intended for parentral administration in large volumes shall be pyrogen free and tested for pyrogens .if water or any other aqueous solvent is supplied along with the substances for preparing such solutions ,it shall also be pyrogens free and tested for pyrogens